ID29546A - Polinukleotida dengan rantai yang diperpendek dan metode pembuatannya - Google Patents

Polinukleotida dengan rantai yang diperpendek dan metode pembuatannya

Info

Publication number
ID29546A
ID29546A IDW00200101678A ID20011678A ID29546A ID 29546 A ID29546 A ID 29546A ID W00200101678 A IDW00200101678 A ID W00200101678A ID 20011678 A ID20011678 A ID 20011678A ID 29546 A ID29546 A ID 29546A
Authority
ID
Indonesia
Prior art keywords
chain
polinukleotida
shorted
making
same
Prior art date
Application number
IDW00200101678A
Other languages
English (en)
Inventor
Shinji Matsuyama
Kouichi Ishiyama
Junzo Seki
Tadaaki Ohgi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of ID29546A publication Critical patent/ID29546A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW00200101678A 1999-02-15 2000-02-14 Polinukleotida dengan rantai yang diperpendek dan metode pembuatannya ID29546A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3596399 1999-02-15

Publications (1)

Publication Number Publication Date
ID29546A true ID29546A (id) 2001-09-06

Family

ID=12456623

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101678A ID29546A (id) 1999-02-15 2000-02-14 Polinukleotida dengan rantai yang diperpendek dan metode pembuatannya

Country Status (14)

Country Link
US (2) US6780429B1 (id)
EP (1) EP1153931B1 (id)
KR (1) KR100455814B1 (id)
CN (1) CN1194002C (id)
AT (1) ATE299885T1 (id)
AU (1) AU2460900A (id)
BR (1) BR0008227A (id)
CA (1) CA2359674A1 (id)
DE (1) DE60021354T2 (id)
ID (1) ID29546A (id)
NO (1) NO20013941L (id)
RU (1) RU2238279C2 (id)
WO (1) WO2000047601A1 (id)
ZA (1) ZA200106701B (id)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958324B2 (en) 1998-12-02 2005-10-25 Inotek Pharmaceuticals Corporation Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
US20010053763A1 (en) * 1998-12-02 2001-12-20 Andrew Salzman Method and composition for modulating an immune response
EP1582584A4 (en) * 2002-12-26 2006-05-31 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING PNPASE
CA2587676A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
EP2281043B1 (en) 2008-04-25 2013-03-13 Innate Pharma Improved tlr3 agonist compositions
EP2116602A1 (en) 2008-05-07 2009-11-11 Institut Gustave Roussy Combination products for treating cancer
CN101352422B (zh) * 2008-09-17 2011-04-20 厦门朝阳生物工程有限公司 河豚毒素冻干粉针制剂及其制备方法
EA201290876A1 (ru) 2010-03-05 2013-03-29 Президент Энд Феллоуз Оф Гарвард Колледж Композиции индуцированных дендритных клеток и их использование
US9814740B2 (en) 2010-12-21 2017-11-14 Duke University Methods and compositions combining immunotherapy with monocyte activation
IN2014MN02492A (id) 2012-06-08 2015-07-17 Aduro Biotech
US9816095B2 (en) 2012-12-06 2017-11-14 Kyowa Hakko Bio Co., Ltd. Double-stranded ribonucleic acid for adjuvants
AU2013358892B2 (en) 2012-12-13 2018-06-21 Aduro Biotech, Inc. Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
SG10201708821RA (en) 2013-04-29 2017-12-28 Memorial Sloan Kettering Cancer Center Compositions and methods for altering second messenger signaling
WO2014179760A1 (en) * 2013-05-03 2014-11-06 The Regents Of The University Of California Cyclic di-nucleotide induction of type i interferon
AP2015008700A0 (en) 2013-05-18 2015-08-31 Univ California Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
US9549944B2 (en) 2013-05-18 2017-01-24 Aduro Biotech, Inc. Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
EP3027227A4 (en) 2013-07-31 2018-05-23 Memorial Sloan Kettering Cancer Center Sting crystals and modulators
JP7252627B2 (ja) 2016-12-15 2023-04-05 デューク ユニバーシティ 制御性ｂ１０細胞を枯渇させる抗体および方法並びに免疫チェックポイント阻害剤との併用における使用
JP2024517181A (ja) 2021-04-28 2024-04-19 ウエヌイグレックオ・ファーマ 組合せ治療としてｆｘｒアゴニストを使用するｔｌｒ３アゴニストの効果の強い増強

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692899A (en) 1969-12-17 1972-09-19 Us Health Education & Welfare Inhibition of transplanted tumor growth by polyinosinic-polycytidylic acid in mice
US3666646A (en) 1970-05-15 1972-05-30 Merck & Co Inc Reduction of molecular weight in polynucleotides using ultrasonic radiation
US5298614A (en) * 1986-01-06 1994-03-29 Nippon Shinyaku Co. Ltd. Size limited double stranded poly I poly(cytidylate/4-thiouridylate)
GB2207138B (en) * 1987-07-03 1992-02-05 Nippon Shinyaku Co Ltd Preparation of nucleic acid derivatives.
CA2156289C (en) * 1993-02-19 2006-01-03 Junichi Yano Drug composition containing nucleic acid copolymer
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5886165A (en) * 1996-09-24 1999-03-23 Hybridon, Inc. Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments

Also Published As

Publication number Publication date
EP1153931A1 (en) 2001-11-14
KR100455814B1 (ko) 2004-11-06
US7223857B2 (en) 2007-05-29
KR20020013500A (ko) 2002-02-20
EP1153931B1 (en) 2005-07-20
EP1153931A4 (en) 2002-07-17
CA2359674A1 (en) 2000-08-17
WO2000047601A1 (fr) 2000-08-17
CN1340055A (zh) 2002-03-13
NO20013941D0 (no) 2001-08-14
US20040235044A1 (en) 2004-11-25
ATE299885T1 (de) 2005-08-15
US6780429B1 (en) 2004-08-24
RU2238279C2 (ru) 2004-10-20
ZA200106701B (en) 2002-11-14
BR0008227A (pt) 2001-10-30
CN1194002C (zh) 2005-03-23
NO20013941L (no) 2001-08-14
AU2460900A (en) 2000-08-29
DE60021354D1 (de) 2005-08-25
DE60021354T2 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
ID29546A (id) Polinukleotida dengan rantai yang diperpendek dan metode pembuatannya
DE59906105D1 (de) Verfahren zur kontinuierlichen herstellung von 1,3-dioxolan-2-onen
ATE478665T1 (de) Verfahren zur herstellung einer polymorphen form von atorvastatin calcium
CO4910133A1 (es) Antagonistas de 5-h[1f]
ATE471924T1 (de) 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'- binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'- octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung
ATE127474T1 (de) Neue peptidasen und isomerasen-inhibitoren.
ATE388135T1 (de) Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen
ID26690A (id) Komposisi katalis, metoda pembuatannya dan metoda pemurnian asam tereftalat
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69231815T2 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE60209537D1 (de) Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander
DE69910113D1 (de) Verfahren zur Herstellung von Stickstofftrifluorid durch Gas-Feststoffreaktion
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
CY1109762T1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
ATE113939T1 (de) Verfahren zur herstellung von cephalosporin und zwischenverbindungen.
ATE385232T1 (de) Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen
ATE201197T1 (de) Diarinopropanole abgeleitet von aminosäuren
DE69015814D1 (de) Verfahren zur Herstellung von Calciumhypochlorit.
BR9808637A (pt) Compostos e método de preparação de ácidos 4-fenil-4 cianociclohexanóico
DE69510798T2 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure
ID21968A (id) Turunan-turunan 11-asetil-12, 13-dioksabisiklo (8.2.1)-tridesenon, proses pembuatannya dan senyawa yang digunakan sebagai obat
DE69611924T2 (de) Verfahren zur herstellung von mangansulfid
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
ATE265421T1 (de) Verfahren zur herstellung von midodrin
ID28020A (id) Senyawa-senyawa sulfonilsianamida tersubstitusi, prose-proses pembuatannya dan penggunaannya sebagai obat